Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

The enzymes Tet2 and Tet3 are important for skin cell development and hair growth.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

5-Alpha-Reductase Inhibitors can cause negative side effects.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

The deltamethrin solution effectively and safely treats and prevents lice in horses for up to one month.

Diuretics help the body get rid of excess salt and water by acting on the kidneys in different ways.

The enzyme system in hair follicles is similar to the liver's and is affected by certain inhibitors.

TCDD changes skin cell growth and keratin production in mice.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Adapalene, Diosmin, and Azelastine could be repurposed to treat onchocerciasis.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

Finasteride can help with hair loss and prostate issues but may negatively affect mood and the nervous system.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

Finasteride, when taken daily, lowers dihydrotestosterone levels but doesn't noticeably affect adrenal steroid production, except by blocking the 5 alpha-reductase enzyme.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.